Kpv Certificate Of Analysis

A KPV certificate of analysis (COA) is an essential quality assurance document providing verified empirical data on the identity, purity, molecular weight, and microbiological safety of synthesized Lysine-Proline-Valine tripeptide reagents. Standardized third-party COAs confirm chemical purity exceeding 98% via RP-HPLC, identity via mass spectrometry, and low endotoxin thresholds prior to preclinical investigation.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

A KPV certificate of analysis (COA) is an essential quality assurance document providing verified empirical data on the identity, purity, molecular weight, and microbiological safety of synthesized Lysine-Proline-Valine tripeptide reagents. Standardized third-party COAs confirm chemical purity exceeding 98% via RP-HPLC, identity via mass spectrometry, and low endotoxin thresholds prior to preclinical investigation.

Reviewed by PX1 Research scientific team

Key takeaways

  • In experimental biochemistry and preclinical pharmacology, a [KPV](/research-peptides/kpv) [certificate of analysis](/research-peptides/what-is-a-coa-for-peptides) serves as the definitive analytical record validating a research compound's identity, chemical purity, and suitability for quantitative assays.
  • [KPV](/research-peptides/kpv) is a C-terminal tripeptide fragment—comprising the amino acid sequence Lysine-Proline-Valine—derived from alpha-melanocyte-stimulating hormone (α-MSH).
  • A rigorous [KPV](/research-peptides/kpv) [certificate of analysis](/research-peptides/what-is-a-coa-for-peptides) must report critical analytical parameters that directly inform experimental integrity.
  • Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) represents the primary gold-standard analytical technique for evaluating the chemical purity of synthesized [KPV](/research-peptides/kpv).

Understanding the KPV Certificate of Analysis in Laboratory Settings

In experimental biochemistry and preclinical pharmacology, a KPV certificate of analysis serves as the definitive analytical record validating a research compound's identity, chemical purity, and suitability for quantitative assays. Because synthesized peptides are susceptible to truncated sequence artifacts, residual counterions, and synthesis reagents, researchers must rely on independent documentation rather than vendor declarations. An authentic COA documents precise batch-specific analytical metrics generated by ISO 17025 accredited analytical laboratories.

When purchasing reagents such as PX1 Research KPV, principal investigators require verified laboratory documentation to ensure experimental reproducibility across cell culture models and animal studies. A robust certificate of analysis details analytical methodologies including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination, Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular weight verification, and Chromogenic LAL assays for bacterial endotoxin quantification. Without these verified metrics, baseline noise and variable bioburden can compromise preclinical research outcomes.

Chemical Structure and Preclinical Mechanisms of KPV Tripeptide

KPV is a C-terminal tripeptide fragment—comprising the amino acid sequence Lysine-Proline-Valine—derived from alpha-melanocyte-stimulating hormone (α-MSH). In preclinical models, α-MSH demonstrates potent anti-inflammatory and immunomodulatory properties, but its full-length sequence exhibits broad melanocortin receptor activity. Research isolates indicate that the tripeptide KPV retains key anti-inflammatory signalling capabilities without triggering systemic melanogenesis.

Preclinical studies suggest that KPV operates primarily via intracellular signaling pathways rather than conventional extracellular melanocortin receptor binding. In vitro data indicate that KPV enters target cells via the pepT1 transporter, localized prominently on intestinal epithelial cells and macrophages. Once internalized, KPV interacts directly with nuclear factor kappa B (NF-κB) subunits, inhibiting NF-κB nuclear translocation and suppressing the downstream transcription of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.

In vitro models evaluating intestinal epithelial barrier integrity have demonstrated that KPV application preserves tight junction protein expression (including zonula occludens-1 and occludin) under inflammatory stress. For investigators exploring gut mucosal homeostasis and colitis models, referencing comprehensive technical documentation in the PX1 research library provides essential context on peptide behavior and experimental design.

Key Parameters Reported on a Third-Party KPV COA

A rigorous KPV certificate of analysis must report critical analytical parameters that directly inform experimental integrity. Every verified lot tested by an independent laboratory provides quantifiable metrics across six essential categories:

1. Product Identity and Chemical Details: Formal chemical name (Lys-Pro-Val), CAS number (67727-92-6), empirical formula (C16H30N4O4), and theoretical monoisotopic molecular weight (342.44 g/mol). 2. Lot and Batch Tracking: Unique lot numbers establishing complete traceability from raw material synthesis to the final lyophilized vial. 3. Physical Appearance: Visual inspection parameters confirming a uniform, white to off-white lyophilized powder free of visible particulate matter or color variance. 4. Chemical Purity (RP-HPLC): Quantified relative peak area expressed as a percentage, establishing that the target sequence comprises at least 98% of the total peptide signal. 5. Identity Verification (Mass Spectrometry): Molecular mass spectrum confirming the exact mass-to-charge ratio (m/z) corresponding to protonated KPV [M+H]+. 6. Endotoxin Quantification: Limulus Amebocyte Lysate (LAL) testing reported in Endotoxin Units per milligram (EU/mg) to confirm acceptable safety thresholds for cellular assays.

RP-HPLC Purity Determination for KPV Tripeptides

Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) represents the primary gold-standard analytical technique for evaluating the chemical purity of synthesized KPV. The RP-HPLC section of a KPV certificate of analysis displays a chromatogram mapping UV absorbance against retention time, resolving the main KPV peak from minor synthesis impurities, deletion sequences, or degradation products.

To achieve reliable chromatographic separation, analytical laboratories utilize hydrophobic stationary phases (such as C18 columns) alongside binary mobile phase gradients typically composed of water and acetonitrile containing 0.1% trifluoroacetic acid (TFA). The relative area under the primary peak compared to total integrated peak area establishes the overall chemical purity percentage. PX1 Research mandates that every batch of KPV achieve a minimum purity threshold of 98.0%, ensuring that researchers working in cell culture or microfluidic barrier assays receive uncompromised active compounds. Researchers interested in sourcing bulk or institutional quantities can explore options via our wholesale research portal.

Mass Spectrometry (ESI-MS) Structural Identification

While RP-HPLC establishes chemical purity, it cannot independently confirm structural identity. Electrospray Ionization Mass Spectrometry (ESI-MS) provides definitive confirmation of the molecular weight of the tripeptide. The ESI-MS spectrum included on an authentic KPV certificate of analysis shows the mass-to-charge ratio (m/z) of ionized species present in the sample.

For KPV ( theoretical molecular weight 342.44 g/mol), ESI-MS analysis operating in positive ion mode reveals a dominant primary peak at m/z 343.2 [M+H]+, representing the singly protonated molecular ion. Additional characteristic adduct peaks, such as [M+Na]+ at m/z 365.2, may appear depending on ionization parameters. The absence of unexpected high-intensity mass peaks validates that the sample is free from misfolded peptide fragments, unblocked protecting groups, or unintended amino acid insertions.

Endotoxin Limits and Microbiological Integrity

Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent biological contaminants capable of invalidating preclinical experimental data. In vitro cell cultures exposed to microgram or even nanogram quantities of endotoxin undergo aberrant toll-like receptor 4 (TLR4) activation, leading to non-specific inflammatory signaling that masks or distorts the actual biological action of KPV.

A compliant KPV certificate of analysis includes explicit LAL endotoxin test results. PX1 Research enforces strict endotoxin specifications, requiring values below 0.01 EU/mg or strictly defined limits appropriate for sensitive tissue culture and animal model protocols. Confirming minimal endotoxin levels ensures that observed anti-inflammatory effects in epithelial or immune cell lines are attributable solely to the Lys-Pro-Val sequence rather than endotoxin-induced artifactual signaling. To review full documentation standards across all product lines, visit our comprehensive catalog of research peptides.

Comparative Analysis: KPV vs. Other Mucosal & Inflammatory Research Peptides

In preclinical gastroenterology and mucosal barrier investigations, KPV is frequently evaluated alongside other peptide reagents targeting intestinal integrity and systemic inflammatory cascades. Understanding how KPV differs structurally and functionally from related compounds helps investigators select the optimal candidate for specific experimental models.

While KPV targets nuclear NF-κB translocation directly via pepT1 uptake, BPC-157 is a 15-amino acid pentadecapeptide researched primarily for angiogenic growth factor upregulation, focal adhesion kinase activation, and tissue repair signaling. Conversely, Larazotide Acetate functions as a synthetic tight junction regulator that acts as an antagonist to zonulin receptors, stabilizing intestinal tight junctions directly without direct intracellular transcriptomic modulation. Researchers interested in exploring related pathways can review detailed technical summaries in our specialized guide on gut-derived research peptides.

Reconstitution, Handling, and Storage Protocols for Laboratory Use

Maintaining the integrity of validated KPV reagents requires strict adherence to standardized laboratory handling and storage protocols. Lyophilized KPV tripeptide is inherently stable when stored at -20°C or -80°C in a desiccated environment protected from light exposure.

Reconstitution should be performed under sterile conditions using appropriate laboratory solvents. Lyophilized KPV exhibits high aqueous solubility and readily dissolves in sterile bacteriostatic water, phosphate-buffered saline (PBS, pH 7.4), or standard cell culture media. For precise concentration calculations, researchers should utilize our verified peptide reconstitution calculator prior to preparing stock solutions. Repeated freeze-thaw cycles must be avoided by dispensing reconstituted stock solutions into single-use aliquots before freezing at -80°C.

Ensuring Supply Chain Integrity and US Manufacturing Standards

The integrity of a certificate of analysis relies entirely on the rigor, independence, and compliance of the testing facility and manufacturer. Certificates generated internally by unverified offshore manufacturers frequently lack raw analytical data, displaying only summarized, unverified text values.

PX1 Research maintains complete batch traceability by utilizing US-based synthesis facilities operating under cGMP-compliant conditions. Every production lot undergoes independent, third-party analytical verification at ISO 17025 accredited testing laboratories based in North America. Each batch of KPV is supplied with complete analytical documentation—including full-spectrum HPLC chromatograms and mass spectra—guaranteeing that USA-manufactured reagents meet exact purity, identity, and bioburden specifications for high-precision scientific research.

Frequently Asked Questions

What is a KPV Certificate of Analysis?

A KPV Certificate of Analysis (COA) is an official analytical report generated by an independent laboratory verifying the identity, chemical purity (RP-HPLC), molecular weight (MS), and endotoxin levels of a specific batch of Lysine-Proline-Valine tripeptide.

What purity level should be documented on a KPV COA?

High-grade laboratory research requires a KPV chemical purity of at least 98.0% as determined by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC).

How is KPV identity verified on the COA?

Identity is confirmed using Mass Spectrometry (ESI-MS), which measures the exact mass-to-charge ratio of the protonated peptide molecule (expected [M+H]+ at m/z 343.2).

Why is endotoxin testing critical for KPV in research?

Endotoxin testing ensures the peptide reagent is free from bacterial lipopolysaccharides that can induce non-specific inflammatory responses, distorting data in cell culture and preclinical cytokine assays.

Where can I view the third-party COA for PX1 Research KPV?

Batch-specific COAs containing full HPLC and mass spec spectra are publicly accessible directly on the PX1 Research product page or available upon request using the batch lot number.

How should KPV be stored once reconstituted in the lab?

Reconstituted KPV stock solutions should be divided into single-use laboratory aliquots and stored at -20°C or -80°C to prevent freeze-thaw degradation.

Is KPV supplied by PX1 Research intended for human administration?

No. KPV provided by PX1 Research is strictly designated for laboratory in vitro and preclinical research use only. It is not for human or veterinary medical, therapeutic, or diagnostic use.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.